ATHA

Athira Pharma, Inc. - Common Stock (ATHA)

About Athira Pharma, Inc. - Common Stock (ATHA)

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Details

Daily high

$3.95

Daily low

$3.80

Price at open

$3.85

52 Week High

$6.08

52 Week Low

$2.20

Market cap

15.3M

Dividend yield

0.00%

Volume

15,525

Avg. volume

18,823

P/E ratio

-.40

Athira Pharma, Inc. - Common Stock News